BIOLOGICAL ACTIVE BULLETS, SYSTEMS, AND METHODS

• US 20160298947A1
• Filed: 06/27/2016
• Published: 10/13/2016
• Est. Priority Date: 05/02/2012
• Status: Active Grant

• Current Assignee: Darren Rubin
• Original Assignee: Darren Rubin
• Inventors: RUBIN, DARREN
• Granted Patent: US 9,945,650 B2
• Time in Patent Office: Days
• US Class Current: 1/1
• CPC Class Codes: F42B 12/54 by implantation, e.g. hypodermic projectiles
• CPC Class Codes: F42B 12/72 characterised by the material heat treatment for explosive shells C21D9/16

Abstract

A hemostatic bullet projectile is for discharge from a firearm and for use as a weapon. The ammunition is a bullet in a cartridge. The bullet projectile includes, and is distinguished by, the use of at least one potentially biological active substance delivered to a bullet wound of a target and serving as a hemostatic agent to promote blood clotting and/or control hemorrhage in the bullet would to stabilize the target until surgery can be performed. Methods are included to promote blood clotting and/or control hemorrhage in at least one bullet wound by delivery of a hemostatic agent by the bullet projectile causing the wound as well as minimizing the risk of embolism from the hemostatic bullet projectile.

Claims

1. A bullet projectile structured to be packaged in a cartridge/shell and structured to be discharged from a firearm and used as a weapon to produce at least one bullet wound in a target;

said bullet projectile including, and distinguished by the use of, at least one potentially biological active substance not involved in the propelling of said bullet projectile to said target;

said at least one potentially biological active substance undergoing at least one physical and or chemical change when said at least one potentially biological active substance comes in contact with and is triggered by and interacts with a bodily fluid of said target, following impact and penetration of said bullet projectile with said target;

said at least one physical and or chemical change producing at least one result in said at least one bullet wound chosen from the group consisting of cauterization, promoting of blood coagulation, absorbing fluid, expansive filling and obstructing within, and applying intracavitary pressure against, said at least one bullet wound to reduce or arrest hemorrhage and to reduce or prevent lethality of said bullet projectile.

2. The bullet projectile as set forth in claim 1 wherein said cauterization is the result of heat produced in at least one exothermic chemical reaction that occurs when said at least one potentially biological active substance comes in contact with and reacts with said bodily fluid in said at least one bullet wound.

3. The bullet projectile as set forth in claim 1 wherein said bacteriocidation is the result of heat produced in at least one exothermic chemical reaction that occurs when said at least one potentially biological active substance comes in contact with and reacts with said bodily fluid in said at least one bullet wound;

said heat lysing or exploding bacterial cells associated with said bullet projectile and or bacterial cells associated with said target'"'"'s skin or clothing brought inside said bullet wound of said target by said bullet projectile.

4. The bullet projectile as set forth in claim 1 wherein said bacteriocidation is the result of destructive oxidation of bacterial cells associated with said bullet projectile and or bacterial cells associated with said target'"'"'s skin or clothing brought inside said bullet wound of said target by said bullet projectile;

said destructive oxidation caused by oxidizing agents released and or produced when said at least one potentially biological active substance comes in contact with and reacts with said bodily fluid in said at least one bullet wound.

5. The bullet projectile as set forth in claim 1 wherein said promoting blood coagulation is the result of the release of clotting factors and platelet-activating mediators from the lysis or exploding of blood platelets from heat produced in at least one exothermic chemical reaction that occurs when said at least one potentially biological active substance comes in contact with and reacts with said bodily fluid, primarily blood, in said at least one bullet wound;

said release of clotting factors and platelet-activating mediators promote a clotting cascade with intact blood platelets.

6. The bullet projectile as set forth in claim 1 wherein said promoting blood coagulation is the result of the release of plasma-derived, recombinant, or synthetic clotting factors, platelet-activating mediators, other organic or inorganic clotting inducers, enzymes, zymogens, enzyme cofactors, signaling molecules, and or surface receptor fragments associated with said bullet projectile to promote a clotting cascade with intact blood platelets.

7. The bullet projectile as set forth in claim 1 wherein said promoting blood coagulation is the result of said at least one potentially biological active substance absorbing aqueous fluid in blood and hemo-concentrating blood platelets, clotting factors, and or platelet-activating mediators.

8. The bullet projectile as set forth in claim 1 wherein said promoting blood coagulation is the result of said at least one potentially biological active substance providing a reactive surface that serves as a clotting substrate.

9. The bullet projectile as set forth in claim 1 wherein said promoting blood coagulation is the result of said at least one potentially biological active substance providing a porous surface or matrix to accumulate blood platelets, clotting factors, and or platelet-activating mediators for initiation of clotting to place on.

10. The bullet projectile as set forth in claim 1 wherein said promoting blood coagulation is the result of said at least one potentially biological active substance attracting blood platelets with an electrostatic charge for blood platelets to accumulate and activate a clotting cascade.

11. The bullet projectile as set forth in claim 1 wherein said promoting blood coagulation is the result of said at least one potentially biological active substance having a mucoadhesive property of attaching to tissues and or blood platelets for blood platelets to accumulate and activate a clotting cascade.

12. The bullet projectile as set forth in claim 1 wherein said promoting blood coagulation within said bullet wound is the result of said at least one potentially biological active substance swelling many times its initial volume within said bullet wound.

13. The bullet projectile as set forth in claim 1 wherein said expansive filling and obstructing within said bullet wound is the result of said at least one potentially biological active substance swelling many times its initial volume within said bullet wound.

14. The bullet projectile as set forth in claim 1 wherein said promoting blood coagulation within said bullet wound is the result of said at least one potentially biological active substance forming a solidifying foam within said bullet wound.

15. The bullet projectile as set forth in claim 1 wherein said expansive filling and obstructing within said bullet wound is the result of said at least one potentially biological active substance forming a solidifying foam within said bullet wound.

16. The bullet projectile as set forth in claim 1 wherein said promoting blood coagulation within said bullet wound is the result of said at least one potentially biological active substance polymerizing within said bullet wound.

17. The bullet projectile as set forth in claim 1 wherein said expansive filling and obstructing within said bullet wound is the result of said at least one potentially biological active substance polymerizing within said bullet wound.

18. The bullet projectile as set forth in claim 1 wherein said promoting blood coagulation within said bullet wound is the result of said at least one potentially biological active substance self-assembling into a matrix or scaffold for blood clotting to take place on.

19. The bullet projectile as set forth in claim 1 further associated with a radiopaque marker or substance that responds to radio-frequency detection so said at least one biological active substance or resulting blood clot can be later located with medical imaging and or instruments and surgically removed.

20. The bullet projectile as set forth in claim 1 wherein said at least one potentially biological active substance is chosen and or sized to minimize the risk of causing an embolism, and or protected from causing an embolism.

21. A bullet projectile structured to be packaged in a cartridge/shell and structured to be discharged from a firearm and used as a weapon to produce at least one bullet wound in a human target;

said bullet projectile is associated with at least one hemostatic agent that is delivered to said at least one bullet wound in said human target upon impact and penetration of said bullet projectile with said human target;

said bullet projectile with hemostatic agent promoting blood clotting and or controlling hemorrhage in said at least one bullet wound more rapidly and or more effectively than standard issue ammunition.

22. A method of promoting blood clotting and or controlling hemorrhage in at least one bullet wound;

said method including the steps of aiming a firearm at a human target and discharging from said firearm a bullet projectile associated with at least one hemostatic agent, and making said at least one hemostatic agent immediately available to interact with blood in said at least one bullet wound of said human target, while minimizing the risk of causing an embolism.